Microfluidics as a Novel Technique for Tuberculosis: From Diagnostics to Drug Discovery

Tuberculosis (TB) remains a global healthcare crisis, with an estimated 5.8 million new cases and 1.5 million deaths in 2020. TB is caused by infection with the major human pathogen Mycobacterium tuberculosis, which is difficult to rapidly diagnose and treat. There is an urgent need for new methods...

Descripción completa

Detalles Bibliográficos
Autores principales: Molloy, Antonia, Harrison, James, McGrath, John S., Owen, Zachary, Smith, Clive, Liu, Xin, Li, Xin, Cox, Jonathan A. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618277/
https://www.ncbi.nlm.nih.gov/pubmed/34835455
http://dx.doi.org/10.3390/microorganisms9112330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618277/
https://www.ncbi.nlm.nih.gov/pubmed/34835455
http://dx.doi.org/10.3390/microorganisms9112330

Ejemplares similares